Treatment with glatiramer acetate delays conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome: subgroup analyses

被引：0

作者：

Comi, Giancarlo ^{[1
,2
]}

Carra, Adriana ^{[3
]}

Fazekas, Franz ^{[4
]}

Rieckmann, Peter ^{[5
]}

Bajenaru, O. ^{[6
]}

Hillert, Jan ^{[7
]}

Elovaara, Irina ^{[8
]}

Young, Carolyn ^{[9
]}

Wynn, Daniel ^{[10
]}

King, John ^{[11
]}

Lubetzki, Catherine ^{[12
]}

Hartung, Hans-Peter ^{[13
]}

Myhr, Kjell-Morten ^{[14
]}

Montalban, Xavier ^{[15
]}

Komoly, Samuel ^{[16
]}

Filippi, Massimo ^{[17
]}

机构：

[1] Ist Sci San Raffaele, I-20132 Milan, Italy

[2] Univ Vita Salute, Dept Neurol, Milan, Italy

[3] Hosp Britan, Buenos Aires, DF, Argentina

[4] Med Univ Graz, Graz, Afghanistan

[5] Univ Bristish Columbia & Vancouver Coastal Hlth, Vancouver, BC, Canada

[6] Carol Davila Univ Med & Pharm, Bucharest, Romania

[7] Karolinska Univ Hosp, Stockholm, Sweden

[8] Univ Tampere, FIN-33101 Tampere, Finland

[9] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England

[10] Neurol Multiple Sclerosis Ctr, Northbrook, IL USA

[11] Royal Melbourne Hosp, Melbourne, Vic, Australia

[12] Hop La Pitie Salpetriere, Paris, France

[13] Univ Dusseldorf, Dusseldorf, Germany

[14] Haukeland Hosp, N-5021 Bergen, Norway

[15] Hosp Univ Vall dHebron, Barcelona, Spain

[16] Univ Pecs, Budapest, Hungary

[17] Ist Sci San Raffaele, I-20132 Milan, Italy

来源：

MULTIPLE SCLEROSIS JOURNAL | 2008年 / 14卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S38 / S38

页数：1

共 50 条

[21] Risk factors for conversion to multiple sclerosis in patients with a clinically isolated syndrome
Neuhaus, A.
Guentner, M.
Morrissey, S. P.
MULTIPLE SCLEROSIS, 2007, 13 : S10 - S10
[22] Metabolome biomarkers for conversion to multiple sclerosis in patients with clinically isolated syndrome
Gasperi, C.
Schafferer, S.
Hoshi, M-M.
Hemmer, B.
Berthele, A.
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 455 - 455
[23] Characterization of the immunophenotye of clinically isolated syndrome patients and conversion to multiple sclerosis
Lee, C. -H.
Nakhaei-Nejad, M.
Barilla, D.
Giuliani, F.
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 837 - 837
[24] Incidence of Conversion to Multiple Sclerosis in Thai Patients with Clinically Isolated Syndrome
Anamnart, C.
Sujjanunt, J.
Prasansiang, C.
Jitpratoom, P.
Siritho, S.
Prayoonwiwat, N.
MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (04) : 521 - 522
[25] CSF proteome analysis in clinically isolated syndrome: candidate markers for conversion to definite multiple sclerosis
Tumani, H.
Lehmensiek, V.
Rau, D.
Guttmann, I.
Tauscher, G.
Sapunova-Meier, I.
Mogel, H.
Ludolph, A.
Brettschneider, J.
JOURNAL OF NEUROLOGY, 2009, 256 : S35 - S35
[26] CSF Proteome Analysis in Clinically Isolated Syndrome (CIS): Biomarkers for Conversion to Definite Multiple Sclerosis
Tumani, Hayrettin
Lehmensiek, Vera
Rau, Daniela
Guttmann, Ivonne
Palm, Christian
Suessmuth, Sigurd D.
Brettschneider, Johannes
NEUROLOGY, 2009, 72 (11) : A197 - A197
[27] Glatiramer Acetate: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis and in Delaying the Onset of Clinically Definite Multiple Sclerosis
Scott, Lesley J.
CNS DRUGS, 2013, 27 (11) : 971 - 988
[28] Glatiramer Acetate: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis and in Delaying the Onset of Clinically Definite Multiple Sclerosis
Lesley J. Scott
CNS Drugs, 2013, 27 : 971 - 988
[29] Non-lesional cerebellar damage in patients with clinically isolated syndrome: DTI measures predict early conversion into clinically definite multiple sclerosis
Kugler, Alexa, V
Deppe, Michael
NEUROIMAGE-CLINICAL, 2018, 19 : 633 - 639
[30] Prognostic Factors for Conversion to Clinically Definite Multiple Sclerosis in an Italian Cohort of Subjects with Clinically Isolated Syndromes
Portaccio, Emilio
Lepore, Vito
Hakiki, Bahia
Zipoli, Valentina
Lorenzo, Razzolini
Comi, Giancarlo
Trojano, Maria
Amato, Maria Pia
NEUROLOGY, 2010, 74 (09) : A66 - A66

← 1 2 3 4 5 →